Today’s announcement raised its stock offering to $20 billion, up from $15 billion yesterday, plus it raised the 30-day option for underwriters to purchase an additional $3 billion in shares, all at a share price of $95. In terms of the number of shares it will sell: 210.5 million shares in the public offering, plus up to 31.6 million additional shares to the underwriters for a maximum of 242.1 million shares. If underwriters execute their 30-day option in full to purchase the additional shares, the share sale would raise the share count by 21% from Q2 2025, to 5.29 million (blue segment in the chart).